STOCKHOLM, Feb. 14, 2020 /PRNewswire/ -- Recruitment for NefIgArd part A completed on plan and budget "In the last quarter of 2019, we achieved a major milestone: the full recruitment of 200 patients for Part A of our pivotal Phase 3 study, NefIgArd. We continue to expect to read out top...